Thus, co-administration of a chemotherapeutic agent with P-gp inhibitors, including verapamil (VER), cyclosporine A, tariquida, and valspodar (PSC833), is used as a promising approach for treating MDR cancer (Bajelan et al., 2012; Sriraman et al., 2015). The gene discussed is PGP; the disease is cancer.